We report that gene silencing via intracytoplasmic microinjections of morpholino-modified antisense oligonucleotides is an effective and reproducible method to study both maternal and zygotic gene functions during early and late stages of mouse preimplantation development. The zygotic expression of the b-geo transgene in the ROSA26 mouse strain could be inhibited until at least the early blastula stages. Thus morpholino-triggered gene inactivation appears to be a useful method to study the functional role of genes in preimplantation development. Using this approach, we have investigated a potential role of maternal expression of Cdh1, the gene encoding the cell-adhesion molecule E-cadherin. Inhibition of translation of maternal E-cadherin mRNA causes a developmental arrest at the two-cell stage. BrUTP incorporation assays indicated that this developmental defect cannot be explained by a general failure in transcriptional activity. This defect is reversible since E-cadherin mRNA can rescue the affected embryos, suggesting that a functional adhesion complex, present at the junction between blastomeres, is a prerequisite for the normal development of the mouse preimplantation embryo. Our study thus reveals a previously unanticipated role of maternal E-cadherin during early stages of mouse development. q
Introduction
In the mouse, oocyte maturation and the initiation of preimplantation development involve the translation of many maternal mRNAs transcribed in the growing oocyte (Oh et al., 2000; Rothstein et al., 1993; Shen-Li et al., 2000; Schultz and Wassarman, 1977; Van Blerkom, 1981) . In this species, activation of the zygotic genome is initiated by the end of the two-cell stage (Schultz, 1993; Wassarman et al., 1979) . Defining the function of the genes operating during these first proliferation and differentiation processes relies on the availability of a rapid and efficient gene inactivation method.
Classical gene knockout methods by homologous recombination in ES cells may not be informative early on because of the presence of maternal transcripts and their protein products in the oocytes generated in heterozygous females. Thus, it seems important to investigate alternative means of inactivating early functions of specific genes.
In the mouse, RNA interference (RNAi) has been recently described as an alternative method to classical gene knockout (Svoboda et al., 2000; Wianny and Zernicka-Goetz, 1999) . This method involves the use of double-stranded RNA, which promotes specific mRNA degradation in the preimplantation embryo. Experimental approaches involving antisense DNA oligonucleotides for altering gene expression through RNA targeting have been widely used during the last decade, but with inconsistent results in the mouse preimplantation embryo (O'Keefe et al., 1989; Paria et al., 1992; Rappolee et al., 1992) . Among the different classes of chemically modified oligonucleotides used in these targeting experiments, morpholino oligonucleotides (MOs) (Summerton, 1999; Ekker and Larson, 2001; Heasman, 2002) have proven to be the most useful. They show excellent base stacking and have been shown to inhibit target genes selectively and efficiently in vitro in cultured cells (Morcos, 2001 ) and more recently, in zebrafish (Nasevicius and Ekker, 2000) , Xenopus (Heasman et al., 2000; Qin et al., 2000) and chicken embryos (Kos et al., 2001) . Morpholino-modified oligonucleotides have also been used in mouse, in early postimplantation embryos (Mellitzer et al., 2002) , as well as in unfertilized oocytes to suppress Mos (originally named c-mos) maternal expression, leading to a phenocopy of the Mos mutation (Coonrod et al., 2001; Colledge et al., 1994; Hashimoto et al., 1994) . Experiments of this nature require the artificial delivery into the oocyte's cytoplasm of an antisense MO designed to bind to a complementary sequence located in close vicinity of the AUG initiation codon of the target mRNA. Upon binding, morpholino oligonucleotides block translation by steric inhibition of the translation initiation complex. However, contrary to standard DNA oligos, MOs do not elicit RNase H activity (Summerton and Weller, 1997) and thus the targeted mRNAs are not degraded (Cazenave et al., 1989) .
We show here that morpholino-modified oligonucleotides can be used to specifically and efficiently inhibit gene expression during mouse preimplantation development from fertilized oocytes up to the blastocyst stage. We describe such knockdown of Cdh1 from the zygote stage onward; these studies reveal a previously unappreciated and essential role of this cell adhesion molecule during the first cleavage stages of the vertebrate embryo.
Results

Selective inhibition of the expression of a b-geo-expressing transgene
To determine whether morpholino oligonucleotides could be used for inhibiting zygotic gene expression during mouse preimplantation development, we used the ROSA26 gene trap strain in which the b-geo reporter gene, which encodes a protein product with strong b-galactosidase (b-Gal) activity, is constitutively expressed (Friedrich and Soriano, 1991; Zambrowicz et al., 1997) . Due to the presence of an ATG codon that can serve to initiate translation in its sequence, this promoter trap reporter gene drives high-level b-geo expression during all stages of embryonic development. Virtually complete penetrance with no variation of b-geo expression has been reported in ROSA26 mice (Zambrowicz et al., 1997) . A MO sequence (anti-b-geo) was designed to recognize a 25-mer region of the ROSA-b-geo mRNA covering the AUG translation start codon. Wild-type superovulated females were mated with ROSA26 homozygous males to ensure that all zygotes possess one allele of the insertion and that b-geo expression is zygotically derived (Fig. 1A) . Microinjection of antib-geo oligonucleotides resulted in a strong downregulation of the b-geo gene, as revealed by LacZ staining performed after two days of culture in vitro, when the embryos had reached the four-to eight-cell stage (Fig. 1C) . Approximately 10 -15% of the anti-b-geo-injected embryos showed no EC.a staining, while the remaining embryos showed a graduation in the intensity of the staining, which rarely reached that of control 4-mis-b-geo-injected embryos (Fig. 1B) . No obvious difference could be observed between the signal intensities of non-injected and control-injected embryos (compare Fig. 1A,B) . To assess the duration of inhibition after morpholino injections at the zygote stage, we performed a series of LacZ stainings one day later, at the late morula to early blastocyst stages (Fig. 1D,E ). Even at these stages, we could observe a significant difference in staining intensity between control 4-mis-b-geo- (Fig. 1D ) and anti-b-geo-injected embryos (Fig. 1E) . Consequently, particularly if the high stability of the b-Gal protein is taken into account, these results provide clear evidence that morpholino oligonucleotides can be used for efficient ablation of gene function during the first stages of mouse preimplantation development, from the zygote stage to the early blastocyst stage. 
Inhibition of E-cadherin expression in fertilized oocytes reveals a maternal function
To investigate further the usefulness of morpholino oligonucleotide-mediated targeting to understand the role of specific genes during preimplantation development, we attempted to inactivate the Cdh1 gene (encoding for E-cadherin, EC) by blocking its translation from the zygote stage onward. We selected Cdh1 because it is both maternally and zygotically expressed during preimplantation development (Ohsugi et al., 1996) . Cdh1 gene inactivation by homologous recombination in embryonic stem cells revealed that null mutant embryos fail to form a trophectodermal epithelium or a blastocyst cavity (Larue et al., 1994; Riethmacher et al., 1995) . Nevertheless, Cdh1
2=2 embryos can undergo compaction; it is unclear, however, whether this is because the function of Cdh1 is not essential during the stages preceding the formation of the blastocyst or because enough maternal E-cadherin protein, and/or maternal mRNA is present. To investigate this problem, we used the morpholino knockdown approach to block translation of mRNAs.
Zygotic cytoplasmic microinjections of anti-EC.a, an antisense morpholino oligonucleotide complementary to nucleotides 2 32 to 2 55 of the 5 0 -UTR region of the E-cadherin mRNA, resulted in an arrest of embryonic development at the two-cell stage (Table 1 and Fig. 2C,F) . Almost all anti-EC.a-injected embryos (up to 98%) were affected when oligonucleotide concentrations of 0.67 and 1 mM were used ( Table 1) . As shown in Table 1 , we observed that this effect is dose-dependent. To confirm this result, we tested a second morpholino oligonucleotide, anti-EC.b, which targets a different area in the 5 0 -UTR of the E-cadherin mRNA (nucleotides 2 10 to 2 34) and shares only three nucleotides with anti-EC.a. E-cadherin targeting was somewhat less efficient with anti-EC.b as shown in Table 1 , but the same phenotype could still be observed for up to 70% of the injected embryos at the doses delivered to the cytoplasm. In contrast, control embryos that had been microinjected with a mispaired oligonucleotide, 4-mis-EC.b, remained unaffected (Table 1 ) and were morphologically indistinguishable from control non-injected embryos (compare Fig. 2A ,B,D,E). This clearly demonstrates the sequence-specificity of the morpholino effect.
Using an anti-E-cadherin specific antibody we performed indirect immunofluorescence two days after MO injection, when control embryos cultured in parallel had reached the four-to eight-cell stage. We observed that E-cadherin expression at the protein level was strongly decreased or absent in most of the anti-EC.a-injected embryos (Fig. 2C,F) . Indeed, compared to control noninjected two-cell embryos (Fig. 2G ), the arrested embryos were negative or showed very weak E-cadherin staining near the cellular contact sites (Fig. 2C ,F). As described above for the b-geo knockdown, we also observe in this case a variation in the severity of the phenotype. The extent of E-cadherin depletion probably varies with the amount of MO solution delivered to the cytoplasm. We did not detect any significant difference in staining intensity between uninjected controls ( Fig. 2A,D ) and 4-mis-EC-injected embryos ( Fig. 2B,E) . Morphologically, the arrested embryos were clearly distinguishable from normal twocell embryos (compare Fig. 2F ,G). The blastomeres of anti-EC.a-injected embryos had a more spherical shape than that generally observed in control embryos, indicating a smaller contact area between the two blastomeres. Surface E-cadherin depletion was also observed for the second MO, anti-EC.b (data not shown). We confirmed this depletion or reduction of E-cadherin expression by Western blotting (Fig. 2P) . Indeed, while the intensities of the E-cadherin specific bands from non-injected and 4-missense injected embryos were comparable, the intensity of the band corresponding to the anti-EC injected embryos was clearly lower. Results are for 48 h of incubation in vitro after intracytoplasmic injection. a At ca. 48 h incubation in vitro after intracytoplasmic injection the unaffected embryos had generally reached the four-to eight-cell stage, the same stage reached by non-injected control embryos.
E-cadherin-mediated cell-adhesion requires a functional E-cadherin -catenin complex. E-cadherin is known to attach to the actin cytoskeleton via proteins known as catenins, which associate with its cytoplasmic domain (Kemler, 1993) . It has been previously shown that b-catenin has a distribution pattern very similar to that of E-cadherin in preimplantation embryos (Ohsugi et al., 1996 (Ohsugi et al., ,1999 . mRNAs corresponding to both genes are present in unfertilized eggs as maternal messages and both genes are transcribed de novo when activation of the zygotic genome occurs (Ohsugi et al., 1997 (Ohsugi et al., ,1999 . In E-cadherin null embryos, a-and b-catenin are not detected or are very weakly expressed in all cell -cell contact sites and the total amount of these proteins is greatly reduced (Ohsugi et al., 1997) . In agreement with this interdependence, we find that the amount of membrane-bound b-catenin is strongly reduced after microinjection of anti-EC.a antisense oligonucleotides, as detected by immunofluorescence staining with an antib-catenin monoclonal antibody (Fig. 2J,M) . Indeed, the strong b-catenin protein expression observable at the blastomere -blastomere contact site in normal two-cell embryos ( Fig. 2N ; Ohsugi et al., 1999) was not observed after MO-treatment. We also note that b-catenin does not appear to accumulate in the nucleus (Fig. 2M) . Thus, the ratio of E-cadherin vs. b-catenin is lower in MO-treated embryos (Fig. 2P) .
To further elucidate the mechanism of the above described two-cell arrest we next asked whether MOarrested embryos failed to acquire phenotypic changes characteristic of six-to eight-cell stage embryos. To this end, we tested whether the cell surface antigen SSEA-1 (Solter and Knowles, 1978) , which normally appears at the late six-to eight-cell stage in control embryos (Fox et al., 1981; Petzoldt, 1986) , is expressed in embryos arrested at the two-cell stage. Immunostaining assays were performed 44 h after anti-EC.a injections, at a time when control embryos had reached the eight-cell stage. No significant SSEA-1 specific signal was observed at the cell-surface of blocked two-cell embryos (Fig. 3). 2.3. The morpholino-induced two-cell block cannot be explained by a global failure in transcriptional activity and can be rescued by E-cadherin mRNA
To show that our E-cadherin knockdown treatments are not causing overall damage to the embryo, we evaluated transcriptional activity in two-cell arrested embryos using microinjected BrUTP (5-bromouridine 5 0 -triphosphate) incorporation (Bouniol et al., 1995) . Endogenous transcription takes place as early as at the late one-cell stage in the mouse and is required for development beyond the two-cell stage (Bouniol et al., 1995; Aoki et al., 1997) . Cytoplasmic microinjections into both blastomeres were performed at the two-cell stage on the morning following the day of the MO injection. A culture period of 60 min following BrUTP injection was adopted in all cases. As detected by immunofluorescence staining using a monoclonal antiBrdUTP antibody, two-cell arrested embryos that had been microinjected with the anti-EC.a oligonucleotide did not show an obvious reduction of transcription (Fig. 4E,F) , when compared with control non-injected (Fig. 4A,B) or 4-mis-EC.b embryos (Fig. 4C,D) .
To definitely ascertain the specificity of the effect of anti-E-cadherin MOs we attempted to rescue anti-EC.a-treated embryos by intracytoplasmic injections of a 5 0 -UTR truncated mouse E-cadherin mRNA (EC-5 0 D-mRNA).
This RNA includes only the first 13 nucleotides of the 5 0 -UTR sequence and therefore cannot be targeted by anti-EC.a. RNA was microinjected into both blastomeres of twocell embryos that were pretreated with anti-E-cadherin morpholino oligonucleotides. In this experiment, the concentration of the anti-EC.a MO was reduced to 0.5 mM which generated arrest at the two-cell stage of only about 75% of injected embryos (Fig. 5A ). As shown in Fig. 5 , EC-5 0 D-mRNA injections into both blastomeres of embryos at the two-cell stage doubled the number of embryos developing at the four-to eight-cell stage (Chi Square test P value # 0.0001). When E-cadherin mRNA containing the morpholino binding site was injected, the rescue was less effective, indicating that the morpholino also inhibited the translation of exogenous mRNAs. In this latter case, the increase in embryos developing further, to the four-to eight-cell stage, was only 10%. When the EC-5 0 D-mRNA was injected only into one blastomere, no significant rescue of the two-cell block was observed (data not shown). The EC-5 0 D-mRNA is efficiently translated into protein that is recognized by anti-E-cadherin antibodies, as demonstrated by injecting mRNAs into single blastomeres and subsequent immunostaining with the anti-E-cadherin antibody (Fig. 5B ). This result also shows that no general defect of E-cadherin translation occurs in MO-treated embryos.
Discussion
The possibility to manipulate the mouse preimplantation embryo in vitro makes a method enabling gene targeting by direct microinjection of antisense oligonucleotides particularly attractive. We describe the design and analysis of such an approach involving cytoplasmic microinjections of morpholino-modified antisense oligonucleotides.
We report the successful targeting of two different genes through intracytoplasmic microinjection of such molecules into zygotes. At the beginning of our study, we targeted the c-mos gene and observed the same phenotype as described by Coonrod et al., 2001 ) (data not shown). We first demonstrate the effective elimination of expression of the b-geo reporter gene of the ROSA26 mouse strain during preimplantation development. The inactivation of this transgene, which is normally ubiquitously expressed during embryonic development, shows that morpholino oligonucleotides injected at the zygote stage can inhibit the function of genes up to the early blastocyst stage. Resumption of b-geo expression observed at later stages may be due to the degradation of the MO molecules in the cytosol or to their dilution when development proceeds. The experiments undertaken in this study do not permit us to distinguish between these two possibilities.
The precompaction defect obtained here after microinjection of two distinct antisense MOs, anti-EC.a and anti-EC.b, designed to target the E-cadherin mRNA, illustrates the high efficacy with which morpholinos are able to turn off maternally transcribed genes. Both anti-E-cadherin oligonucleotides generated an arrest of embryonic development at the two-cell stage, accompanied by down-regulation of E-cadherin expression. A similar phenotype was not observed in control experiments performed in parallel with a corresponding 4-missensed oligonucleotide. In addition, no other oligonucleotide used in our knockdown experiments led to such an arrest after the first cleavage. These results indicate the specificity of the phenotype obtained here.
Transcriptional activity assayed by BrUTP incorporation and indirect immunofluorescence appeared to be unaffected in two-cell stage arrested embryos as late as 19 h after MO microinjection. The specificity of the anti-E-cadherin MO-triggered phenotype was further ascertained by rescue experiments involving a truncated E-cadherin mRNA. Indeed, a significant percentage of two-cell arrested embryos ðP # 0:001Þ that had been injected with an E-cadherin mRNA lacking the anti-E-cadherin MO binding site progressed through the second cleavage stage and developed further normally up to the blastocyst stage. Our rescue experiments clearly demonstrate that the MO-induced embryonic arrest is reversible and thus can not be simply attributed to non-specific secondary effects of the MOs or to apoptosis.
The hypothesis of a functional role for E-cadherin in the transition of a morphologically non-polarized entity, the fertilized egg, into a polarized structure, the morula is also supported by previous studies showing that the loss of E-cadherin does not cause general cell lethality. Indeed, it is possible to obtain in vitro outgrowth of Cdh1 null preimplantation embryos and to derive ES cell lines from these cultures (Larue et al., 1994) . The present results together with those previously obtained for E-cadherin knockout embryos (Larue et al., 1994) , indicate that the continuous translation of maternal E-cadherin mRNA is required for the early cleavage stages, while zygotic E-cadherin gene expression is required for the formation of an intact trophectoderm. Although the integrity of the adhesion complex may be necessary for intercellular communication, this seems unlikely as an explanation for this requirement since isolated blastomeres from two-, fouror eight-cell embryos have been shown to re-capitulate the early cleavages (Tarkowski, 1959; Tarkowski and Wroblewska, 1967; Rossant, 1976) . Rather, disruption of the adhesion complex might alter the distribution of b-catenin in different cellular compartments, and, given its role as a transcriptional regulator (Arnold et al., 2000; Behrens et al., 1996; Lickert et al., 2000; Molenaar et al., 1996) , may lead to an aberrant pattern in gene activity. The E-cadherin phenotype obtained here is different from the one reported for the RNA interference (RNAi) method, which employs double-stranded RNA (Wianny and Zernicka-Goetz, 1999) . Indeed, the phenotype obtained with RNAi, namely a failure to form a blastocoel at the late compaction stage, was described as being identical to the one initially reported for the E-cadherin null mutant. In the case of RNAi, the efficiency of E-cadherin maternal mRNA degradation was reported to be variable (Wianny and Zernicka-Goetz, 1999 ). At present, we do not know the reason for the difference between the effects of these two types of knockdown approaches. One advantage of the RNAi method is that the knockdown effect can be easily confirmed by RNA assays, while in the case of the morpholino approach a specific antibody is required.
While we are confident that morpholino oligonucleotides can be successfully used to inhibit mRNA translation during early mouse development, we note that this procedure requires attention to several experimental variables. First, the delivery of optimal oligonucleotide doses appeared to be an essential factor for the successful targeting of a given gene. Second, we found an apparent upper concentration limit for each oligonucleotide, with too high concentrations rendering the microinjection procedure difficult or impossible. Optimal concentrations of oligonucleotides were observed to range between 0.67 and 2 mM.
In comparison to a conventional gene knockout experiment, a noticeable advantage of the morpholino-based knockdown approach resides in the possibility to obtain hypomorphic phenotypes, because one can titrate the amount of morpholino oligonucleotides that is injected. Thus, the function of the targeted gene can be incompletely or fully inhibited. This method should also allow one to disturb gene expression in specific cells or blastomeres of the developing embryo, while leaving the remaining ones unaffected. Moreover, interference with transcriptional processing (pre-mRNA splicing) of newly synthesized, e.g. zygotically synthesized transcripts, could represent an alternative approach to selectively target part of the mRNA pool (Draper et al., 2001) . When considered in the present context, oligonucleotides interfering with the splicing process would allow the function of a given maternal gene to be studied in the absence of a zygotic contribution.
Materials and methods
Oocyte and fertilized egg collection and in vitro culture
Mice were bred in the animal facility of the Max-Planck Institute of Immunobiology (Freiburg, Germany). Ovulated oocytes and fertilized eggs were collected from oviducts of FVB/N mice superovulated with pregnant mare serum gonadotropin (PMSG; Intervet) and human chorionic gonadotropin (hCG; Intervet), 18 -19 h posthCG injection, by tearing the ampulla of the oviduct and collecting the cumulus mass. Surrounding cumulus cells were removed by treatment with 300 mg/ml hyaluronidase (H-3884, Sigma) in M2 medium (Hogan et al., 1986; M-7167, Sigma) . Embryos were harvested and cultured in KSOM medium (MR-020P-F, Specialty Media) under mineral oil (H-3884; Sigma) at 37 8C in a humidified atmosphere with 5% CO 2 in air. In control experiments, uninjected zygotes rarely arrested at the two-cell stage and generally developed up to the blastocyst stage under our culture conditions. For the experiments involving the ROSA26 strain (The Jackson Laboratory, Bar Harbor, ME), embryos were recovered from crosses between wild-type FVB/N or C57Bl/ 6 £ BALB/c F1 females and homozygous ROSA26 males.
Morpholino oligonucleotides
Morpholino oligonucleotides, 21 -25 nucleotides in length, were purchased from Gene Tools, LLC (Corvallis, OR, USA). Sequences were selected by design parameters according to the manufacturer's recommendations, namely approximately 50% G/C and A/T content with no predicted hairpins. Morpholinos were designed for blocking translational initiation by binding to the 5 0 UTR or sequences flanking the AUG initiating methionine. Using homology searches (BLAST and Celera searches), we also systematically tested each sequence for possible interaction with other sequences within the mouse genome. The following sequences were used: The CAT sequence complementary to the start codon is underlined in the case of a molecule binding to a sequence containing the AUG. The anti-Mos sequence was designed to be complementary to the first 25 nucleotides of the Mos mRNA sequence (GenBank accession number NM-020021). The anti-b-geo sequence is complementary to a stretch of the AUG region of the ROSA-b-geo insertion (Zambrowicz et al., 1997) . Both morpholinos directed against Cdh1 (the gene encoding for E-cadherin), anti-EC.a and anti-EC.b, are complementary to the 5 0 -UTR of the Cdh1 mRNA (GenBank accession number NM-009864). Anti-EC.a and anti-EC.b have only three nucleotides in common (indicated in bold). Control morpholino oligonucleotides (4-mispaired oligos) designed by GeneTools as antisense sequences had four mismatches appropriately distributed along the sequence. For microinjection, MOs were diluted in water to final concentrations ranging from 0.67 to 2.3 mM. The range of effective concentrations was determined individually for each molecule.
mRNA preparation
An E-cadherin mRNA 5 0 -truncated for most of the 5 0 -UTR (EC-5 0 D-mRNA) was synthetized by in vitro transcription of a pBluescript SK(þ ) plasmid, pSK-Ecadh (linearized with HindIII) containing a fragment of the mouse E-cadherin cDNA (Ozawa et al., 1989) . This fragment contains only the last 13 nucleotides of the 5 0 -UTR sequence and thus lacks the anti-EC.a binding site. In another set of assays, this plasmid was modified by the addition of an extra stretch of 5 0 -UTR sequence containing the target sequence of the anti-EC.a morpholino oligonucleotide. Two complementary oligonucleotides, 5 0 -gatccgccctgcccgaccgcacccgagct-3 0 and 5 0 -gatcagctcgggtgcggtcgggcagggcg-3 0 were annealed and the resulting adapter sequence was subcloned into the Bgl II site of pSK-E-cadh. Sequences of the resulting subclones were confirmed by sequencing. For in vitro transcription this plasmid was also linearized with HindIII. Capped RNAs used for intracytoplasmic microinjections were transcribed in vitro from linearized plasmids using T3 RNA polymerase (mMessage mMachine kit, Ambion). The plasmid template DNA was eliminated by incubation for 15 min at 37 8C with DNaseI. mRNAs were phenol/chloroform extracted and ethanol precipitated. For obtaining concentrated preparations, five different transcription reactions were performed in parallel, pooled and concentrated under vacuum to a final volume of 50 ml in RNase free water. In order to obtain RNA preparations suitable for microinjection, the samples were further purified by chromatography using RNase-free Micro Bio-Spin P30 Columns (Bio-Rad) previously equilibrated with 10 mM Tris-HCl; pH 7.5; 0.15 mM EDTA. The approximate size and quality of the transcription products were assessed by running an aliquot on an agarose gel. The quality of mRNA was further checked by translation assays using the Biotin in vitro Translation kit (Roche Mol. Biochemicals). The concentration of mRNA in the injection buffer ranged between 2 and 5 mg/ml.
Intracytoplasmic microinjections
Morpholino oligonucleotides were microinjected into the cytoplasm of zygotes cultured in M2 medium 24-26 h post-hCG injection, using an Axiovert 200 microscope (Zeiss, Germany) equipped with hydraulic micromanipulation systems (Narishige, Japan). Each embryo received a dose of approximately 20 -40 pl of a given oligonucleotide or mRNA solution. Embryonic death rate was dependent on the quality of the injection needle, which is difficult to optimize in the case of cytoplasmic injections. In the case of in vitro transcriptional activity assays and of rescue experiments, respectively, BrUTP and mRNAs were microinjected in the cytoplasm of two-cell embryos, either into one or both blastomeres.
LacZ staining
Embryos were fixed in 2% paraformaldehyde/0.2% glutaraldehyde for 5 -10 min at room temperature, washed briefly in PBS, transferred into freshly prepared X-Gal staining solution (5 mM K þ -ferricyanide, 5 mM K þ -ferrocyanide, 2 mM MgCl 2 , 0.01% SDS, 0.02% NP-40, 0.1% X-Gal), and stained at 37 8C in the dark until the coloration of the control non-injected and mismatched 4-mis-b-geoinjected embryos had reached a strong intensity. Note that all the embryos stained at a given developmental stage were always fixed at the same time and processed in parallel, using the same solutions and incubation time during the whole procedure. After rinsing with PBS, embryos were postfixed in 2% paraformaldehyde and photographed with an Axiocam digital camera (Zeiss, Germany) using fixed parameters and exposure times in order to produce quantitatively comparable images.
Antibodies
The following antibodies were used: against E-cadherin, anti-gp84, a polyclonal affinity-purified rabbit antibody (Vestweber and Kemler, 1984) ; against b-catenin, a mouse monoclonal antibody (C19220, Transduction Laboratories); against Actin, a polyclonal rabbit antibody (A 2066, Sigma) and against stage-specific embryonic antigen 1 (SSEA-1), a mouse monoclonal antibody (MC-480, Developmental Studies Hybridoma Bank). The following secondary antibodies were used for revealing the complexes: a fluorescein (DTAF)-conjugated anti-rabbit IgG (H þ L) antibody (Jackson Immunoresearch Laboratories, Bar Harbor, ME) for E-cadherin; a rhodamine (TRITC)-conjugated donkey anti-rabbit IgG antibody (Jackson Immunoresearch Laboratories) for b-catenin and an Alexa Fluor 546 goat anti-mouse IgM (A-21045, Molecular Probes) for SSEA-1.
Indirect immunofluorescence
Embryos were fixed in 2% paraformaldehyde in PBS for 10 min at room temperature. They were permeabilized with 0.25% Triton X-100 in PBS for 10 min at room temperature. After pretreatment with 1% heat-inactivated sheep serum in PBS (antibody incubation buffer) for 30 min, embryos were incubated with the primary antibody for 30 min at 37 8C. Embryos were then washed in the incubation buffer for 15 min and with 3 mg/ml polyvinyl pyrrolidone in PBS for 15 min at room temperature. Complexes were revealed by a 30 min incubation at 37 8C with the secondary antibodies. Embryos were then washed in incubation buffer and mounted. The following protocol was used in the case of the SSEA-1 immunostaining. Embryos were kept at 37 8C during the whole procedure. They were washed twice in M2 medium and incubated in acidic Tyrode's solution (T-1788, Sigma) until complete dissolution of the zona pellucida. After two washes in M2 medium, they were incubated with the SSEA-1 antibody, washed twice in M2 medium, incubated with the secondary antibody, washed twice in M2 medium and mounted. Embryos were mounted in a drop of Prolong Antifade reagent (P-7481, Molecular Probes) and examined under an Axiovert 200 microscope (Zeiss) equipped with epifluorescence microscopy for photography with an Axiocam digital camera (Zeiss), using fixed parameters and exposure times in order to produce comparable images.
Immunoblotting
Western blots were performed as described by Ohsugi et al., 1996. For revealing E-cadherin and b-catenin expression the same antibodies as for indirect immunofluorescence were used. Dilutions of the first antibodies were as follows: anti-gp84, 1/1000; anti-b-catenin, 1/500; anti-actin, 1/500. For detecting bound first antibodies on the membranes, specific peroxydase-conjugated and affinitypurified secondary antibodies from Jackson Immunoresearch Laboratories, were used at a 1/1000 dilution.
In vitro transcriptional activity assay
Single blastomere intracytoplasmic microinjections were performed in two-cell stage embryos (approximately 45 h after hCG injection) with 10 mM BrUTP (Sigma No. B-7166) prepared in 0.2 mM glucose. The injected volume was approximately 5% of the blastomere volume. After a further 60 min incubation in vitro in KSOM medium (MR-020P-F, Specialty Media) at 37 8C in a humidified atmosphere with 5% CO 2 in air, embryos were fixed and processed for indirect immunofluorescence. Incubations with the first antibody (monoclonal mouse IgG1 antiBrdUTP (1 170 376, Roche), diluted 1/100 and second antibody (Alexa Fluor 488 goat anti-mouse IgG (H þ L) (A-11029, Molecular Probes), diluted 1/200 were both performed for 30 min at 37 8C.
